These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17052861)

  • 21. [Addiction and brief-systemic therapy: working with compulsion].
    Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
    Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research needs grants, funding and money--missing something?
    Ioannidis JP
    Eur J Clin Invest; 2012 Apr; 42(4):349-51. PubMed ID: 22050119
    [No Abstract]   [Full Text] [Related]  

  • 25. What's next in translational medicine?
    Littman BH; Di Mario L; Plebani M; Marincola FM
    Clin Sci (Lond); 2007 Feb; 112(4):217-27. PubMed ID: 17223795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative.
    Baer GR; Nelson RM;
    Clin Ther; 2006 Sep; 28(9):1399-407. PubMed ID: 17062312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invisible colleges, private patronage and commercial profits versus public goods, government funding and 'crowding-out': Terence Kealey on the motivations and incentives driving science.
    Charlton BG
    Med Hypotheses; 2009 Feb; 72(2):111-5. PubMed ID: 18977606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based policy-making: the implications of globally-applicable research for context-specific problem-solving in developing countries.
    Behague D; Tawiah C; Rosato M; Some T; Morrison J
    Soc Sci Med; 2009 Nov; 69(10):1539-46. PubMed ID: 19781839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unconventional allies: interdisciplinary approaches to science policy and funding.
    Goldstein LS
    Trends Cell Biol; 2010 Dec; 20(12):695-8. PubMed ID: 21106464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomedical research funding: when the game gets tough, winners start to play.
    Ascoli GA
    Bioessays; 2007 Sep; 29(9):933-6. PubMed ID: 17688241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Productivity and career paths of previous recipients of Society for Academic Emergency Medicine research grant awards.
    Young KD; ;
    Acad Emerg Med; 2008 Jun; 15(6):560-6. PubMed ID: 18616445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical innovation prize fund: new idea in drug development.
    James JS
    AIDS Treat News; 2005 May; (412):6. PubMed ID: 16047411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Hyper-Commons: how open science prizes can expand and level the medical research playing field.
    Hynek P
    Rejuvenation Res; 2008 Dec; 11(6):1065-72. PubMed ID: 19119862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research funding and mentoring in family medicine residencies.
    Young RA; DeHaven MJ; Passmore C; Baumer JG; Smith KV
    Fam Med; 2007 Jun; 39(6):410-8. PubMed ID: 17549650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Financial anatomy of neuroscience research.
    Dorsey ER; Vitticore P; De Roulet J; Thompson JP; Carrasco M; Johnston SC; Holloway RG; Moses H
    Ann Neurol; 2006 Dec; 60(6):652-9. PubMed ID: 17192926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Department of defense R & d in the university.
    Glantz SA; Albers NV
    Science; 1974 Nov; 186(4165):706-11. PubMed ID: 17792255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.
    Conen D; Torres J; Ridker PM
    Circulation; 2008 Sep; 118(13):1321-7. PubMed ID: 18779441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scientific prize network predicts who pushes the boundaries of science.
    Ma Y; Uzzi B
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12608-12615. PubMed ID: 30530666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for successful patient oriented research: why did I (not) get funded?
    Agarwal R; Chertow GM; Mehta RL
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):340-3. PubMed ID: 17699226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.